Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE

CLINDAMYCIN PHOSPHATE

Standard Dose
EQ 600MG BASE/50ML (EQ 12MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE is listed in Drugs@FDA under application 208083 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CLINDAMYCIN PHOSPHATE Form and strength SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2022-09-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE is listed in Drugs@FDA under application 208083 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CLINDAMYCIN PHOSPHATE Form and strength SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2022-09-01 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE (CLINDAMYCIN PHOSPHATE) | Drug Monograph | MedicHelpline